{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:43:36Z","timestamp":1752230616240,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00228-019-02758-2","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:19:22Z","timestamp":1571703562000},"page":"97-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacological treatment patterns in heart failure: a population-based cohort study"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9763-5974","authenticated-orcid":false,"given":"Pauline","family":"Bosco-L\u00e9vy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9lia","family":"Favary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9my","family":"Jov\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9gis","family":"Lassalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Droz-Perroteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"2758_CR1","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP, Dahlstr\u00f6m U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L, on behalf of the Heart Failure Association of the European Society of Cardiology (HFA) (2013) EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 15:808\u2013817. \nhttps:\/\/doi.org\/10.1093\/eurjhf\/hft050","journal-title":"Eur J Heart Fail"},{"key":"2758_CR2","unstructured":"de Peretty C, P\u00e9rel C, Tuppin P et al (2014) Prevalence and functional status of coronary heart diseases and heart failure in the adult population in France: contribution of the \u201cDisabilities and Health\u201d cross-sectional surveys. BEH"},{"key":"2758_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger VL (2013) Epidemiology of heart failure. Circ Res 113:646\u2013659. \nhttps:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300268","journal-title":"Circ Res"},{"key":"2758_CR4","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despr\u00e9s JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire D, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2015) Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 131:e29\u2013e322. \nhttps:\/\/doi.org\/10.1161\/CIR.0000000000000152","journal-title":"Circulation"},{"key":"2758_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.acvd.2014.01.012","volume":"107","author":"P Tuppin","year":"2014","unstructured":"Tuppin P, Cuerq A, de Peretti C, Fagot-Campagna A, Danchin N, Juilli\u00e8re Y, Alla F, Allemand H, Bauters C, Drici MD, Hag\u00e8ge A, Jondeau G, Jourdain P, Leizorovicz A, Paccaud F (2014) Two-year outcome of patients after a first hospitalization for heart failure: a national observational study. Arch Cardiovasc Dis 107:158\u2013168. \nhttps:\/\/doi.org\/10.1016\/j.acvd.2014.01.012","journal-title":"Arch Cardiovasc Dis"},{"key":"2758_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.acvd.2016.01.011","volume":"109","author":"P Tuppin","year":"2016","unstructured":"Tuppin P, Rivi\u00e8re S, Rigault A, Tala S, Drouin J, Pestel L, Denis P, Gastaldi-M\u00e9nager C, Gissot C, Juilli\u00e8re Y, Fagot-Campagna A (2016) Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database. Arch Cardiovasc Dis 109:399\u2013411. \nhttps:\/\/doi.org\/10.1016\/j.acvd.2016.01.011","journal-title":"Arch Cardiovasc Dis"},{"key":"2758_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","volume":"10","author":"K Dickstein","year":"2008","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10:933\u2013989. \nhttps:\/\/doi.org\/10.1016\/j.ejheart.2008.08.005","journal-title":"Eur J Heart Fail"},{"key":"2758_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","volume":"14","author":"JJV McMurray","year":"2012","unstructured":"Authors\/Task Force Members, McMurray JJV, Adamopoulos S et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail 14:803\u2013869. \nhttps:\/\/doi.org\/10.1093\/eurjhf\/hfs105","journal-title":"Eur J Heart Fail"},{"key":"2758_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00228-014-1794-7","volume":"71","author":"C Vorilhon","year":"2014","unstructured":"Vorilhon C, Chenaf C, Mulliez A, Pereira B, Clerfond G, Authier N, Jean F, Motreff P, Citron B, Eschalier A, Lusson JR, Eschalier R (2014) Heart failure prognosis and management in over-80-year-old patients: data from a French national observational retrospective cohort. Eur J Clin Pharmacol 71:251\u2013260. \nhttps:\/\/doi.org\/10.1007\/s00228-014-1794-7","journal-title":"Eur J Clin Pharmacol"},{"key":"2758_CR10","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.acvd.2013.08.002","volume":"106","author":"P Tuppin","year":"2013","unstructured":"Tuppin P, Cuerq A, de Peretti C, Fagot-Campagna A, Danchin N, Juilli\u00e8re Y, Alla F, Allemand H, Bauters C, Drici MD, Hag\u00e8ge A, Jondeau G, Jourdain P, Leizorovicz A, Paccaud F (2013) First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up. Arch Cardiovasc Dis 106:570\u2013585. \nhttps:\/\/doi.org\/10.1016\/j.acvd.2013.08.002","journal-title":"Arch Cardiovasc Dis"},{"key":"2758_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/pds.4233","volume":"26","author":"J Bezin","year":"2017","unstructured":"Bezin J, Duong M, Lassalle R, Droz C, Pariente A, Blin P, Moore N (2017) The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf 26:954\u2013962. \nhttps:\/\/doi.org\/10.1002\/pds.4233","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2758_CR12","first-page":"6","volume":"582","author":"V Gilleron","year":"2018","unstructured":"Gilleron V, Gasnier-Duparc N, Hebbrecht G (2018) Certification des comptes: Une incitation \u00e0 la tra\u00e7abilit\u00e9 des processus de contr\u00f4le. Revue Hospitaliere de France 582:6","journal-title":"Revue Hospitaliere de France"},{"key":"2758_CR13","unstructured":"(2016) M\u00e9thodologie g\u00e9n\u00e9rale de la cartographie des pathologies d\u00e9velopp\u00e9e par la CnamTS pour les ann\u00e9es 2012\u20132013-2014. Caisse Nationale d\u2019Assurance Maladie (CNAM)"},{"key":"2758_CR14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jchf.2016.02.017","volume":"4","author":"JR Kapoor","year":"2016","unstructured":"Kapoor JR, Kapoor R, Ju C, Heidenreich PA, Eapen ZJ, Hernandez AF, Butler J, Yancy CW, Fonarow GC (2016) Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction. JACC Heart Fail 4:464\u2013472. \nhttps:\/\/doi.org\/10.1016\/j.jchf.2016.02.017","journal-title":"JACC Heart Fail"},{"key":"2758_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3889\/oamjms.2015.087","volume":"3","author":"LV Miljkovik","year":"2015","unstructured":"Miljkovik LV, Spiroska V (2015) Heart failure with preserved ejection fraction \u2013 concept, pathophysiology, diagnosis and challenges for treatment. Open Access Maced J Med Sci 3:521\u2013527. \nhttps:\/\/doi.org\/10.3889\/oamjms.2015.087","journal-title":"Open Access Maced J Med Sci"},{"key":"2758_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","volume":"6","author":"JE Ho","year":"2013","unstructured":"Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, Levy D (2013) Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail 6:279\u2013286. \nhttps:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.972828","journal-title":"Circ Heart Fail"},{"key":"2758_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/eurjhf\/hfs189","volume":"15","author":"D Logeart","year":"2013","unstructured":"Logeart D, Isnard R, Resche-Rigon M, Seronde MF, de Groote P, Jondeau G, Galinier M, Mulak G, Donal E, Delahaye F, Juilliere Y, Damy T, Jourdain P, Bauer F, Eicher JC, Neuder Y, Trochu JN, on behalf of the working group on Heart Failure of the French Society of Cardiology (2013) Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study. Eur J Heart Fail 15:465\u2013476. \nhttps:\/\/doi.org\/10.1093\/eurjhf\/hfs189","journal-title":"Eur J Heart Fail"},{"key":"2758_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.acvd.2013.11.002","volume":"107","author":"E Donal","year":"2014","unstructured":"Donal E, Lund LH, Oger E, Hage C, Persson H, Reynaud A, Ennezat PV, Bauer F, Sportouch-Dukhan C, Drouet E, Daubert JC, Linde C, KaRen Investigators (2014) Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study. Arch Cardiovasc Dis 107:112\u2013121. \nhttps:\/\/doi.org\/10.1016\/j.acvd.2013.11.002","journal-title":"Arch Cardiovasc Dis"},{"key":"2758_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","volume":"3","author":"G Savarese","year":"2017","unstructured":"Savarese G, Lund LH (2017) Global public health burden of heart failure. Card Fail Rev 3:7\u201311. \nhttps:\/\/doi.org\/10.15420\/cfr.2016:25:2","journal-title":"Card Fail Rev"},{"key":"2758_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jjcc.2009.09.003","volume":"55","author":"H Tsutsui","year":"2010","unstructured":"Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S (2010) Clinical characteristics and outcomes of heart failure with preserved ejection fraction: lessons from epidemiological studies. J Cardiol 55:13\u201322. \nhttps:\/\/doi.org\/10.1016\/j.jjcc.2009.09.003","journal-title":"J Cardiol"},{"key":"2758_CR21","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1111\/bcp.13291","volume":"83","author":"P Blin","year":"2017","unstructured":"Blin P, Dureau-Pournin C, Lassalle R, Jov\u00e9 J, Thomas-Delecourt F, Droz-Perroteau C, Danchin N, Moore N (2017) Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: a cohort study in the French national claims database. Br J Clin Pharmacol 83:2056\u20132065. \nhttps:\/\/doi.org\/10.1111\/bcp.13291","journal-title":"Br J Clin Pharmacol"},{"key":"2758_CR22","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1345\/aph.1G124","volume":"39","author":"GH Skrepnek","year":"2005","unstructured":"Skrepnek GH, Abarca J, Malone DC, Armstrong EP, Shirazi FM, Woosley RL (2005) Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs. Ann Pharmacother 39:1785\u20131791. \nhttps:\/\/doi.org\/10.1345\/aph.1G124","journal-title":"Ann Pharmacother"},{"key":"2758_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.18553\/jmcp.2016.22.5.561","volume":"22","author":"C Deschaseaux","year":"2016","unstructured":"Deschaseaux C, McSharry M, Hudson E et al (2016) Treatment initiation patterns, modifications, and medication adherence among newly diagnosed heart failure patients: a retrospective claims database analysis. J Manag Care Spec Pharm 22:561\u2013571. \nhttps:\/\/doi.org\/10.18553\/jmcp.2016.22.5.561","journal-title":"J Manag Care Spec Pharm"},{"key":"2758_CR24","first-page":"1893","volume":"73","author":"M Tsuchihashi-Makaya","year":"2009","unstructured":"Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S et al (2009) Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J Off J Jpn Circ Soc 73:1893\u20131900","journal-title":"Circ J Off J Jpn Circ Soc"},{"key":"2758_CR25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","volume":"50","author":"GC Fonarow","year":"2007","unstructured":"Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O\u2019Connor CM, Sun JL, Yancy CW, Young JB (2007) Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry. J Am Coll Cardiol 50:768\u2013777. \nhttps:\/\/doi.org\/10.1016\/j.jacc.2007.04.064","journal-title":"J Am Coll Cardiol"},{"key":"2758_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376:875\u2013885. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(10)61198-1","journal-title":"Lancet"},{"key":"2758_CR27","first-page":"449","volume":"11","author":"R Sikka","year":"2005","unstructured":"Sikka R, Xia F, Aubert RE (2005) Estimating medication persistency using administrative claims data. Am J Manag Care 11:449\u2013457","journal-title":"Am J Manag Care"},{"key":"2758_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/pds.1230","volume":"15","author":"SE Andrade","year":"2006","unstructured":"Andrade SE, Kahler KH, Frech F, Chan KA (2006) Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15:565\u2013574. \nhttps:\/\/doi.org\/10.1002\/pds.1230","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2758_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/pds.4690","volume":"28","author":"P Bosco-L\u00e9vy","year":"2018","unstructured":"Bosco-L\u00e9vy P, Duret S, Picard F, Dos Santos P, Puymirat E, Gilleron V, Blin P, Chatellier G, Looten V, Moore N (2018) Diagnostic accuracy of the International Classification of Diseases, Tenth Revision, codes of heart failure in an administrative database. Pharmacoepidemiol Drug Saf 28:194\u2013200. \nhttps:\/\/doi.org\/10.1002\/pds.4690","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02758-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02758-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02758-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T23:05:23Z","timestamp":1603148723000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02758-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["2758"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02758-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2019,10,21]]},"assertion":[{"value":"26 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was done in a pseudonymized database, not requiring patient consent. It was reviewed by INSERM internal processes, which did not oppose it. INSERM CIC1401 at that time had permanent access to the 1\/97 sample of SNDS, pending INSERM approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Dr. P. Bosco-L\u00e9vy, C Favary, J Jov\u00e9, R Lassalle, and C Droz-Perroteau have nothing to disclose.Bordeaux PharmacoEpi (director Pr. N. Moore) has received grants from many pharmaceutical companies (Novartis, Bayer, Boehringer Ingelheim, Merck-Serono, etc., see  for a complete list of all research projects) to the University of Bordeaux for regulatory required PASS studies. He declares personal expert consulting fees from Merck-Serono, Ipsen, GSK, Bayer, Sanofi, outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}